Package 55150-928-02

Brand: dactinomycin

Generic: dactinomycin
NDC Package

Package Facts

Identity

Package NDC 55150-928-02
Digits Only 5515092802
Product NDC 55150-928
Product ID 55150-928_f7cacd7d-479f-4a00-8db6-f11ad039b314
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (55150-928-02) / 1 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2021-03-15
Brand dactinomycin
Generic dactinomycin
Sample Package No

Linked Drug Pages (1)

DACTINOMYCIN ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "f7cacd7d-479f-4a00-8db6-f11ad039b314", "openfda": {"nui": ["N0000180850", "N0000000233", "N0000000150"], "unii": ["1CC1JFE158"], "rxcui": ["239179"], "spl_set_id": ["5da55538-2602-4704-a9da-603c9f7ff7dc"], "pharm_class_epc": ["Actinomycin [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Protein Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Eugia US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (55150-928-02)  / 1 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "55150-928-02", "marketing_start_date": "20210315"}], "brand_name": "DACTINOMYCIN", "product_id": "55150-928_f7cacd7d-479f-4a00-8db6-f11ad039b314", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Actinomycin [EPC]", "Nucleic Acid Synthesis Inhibitors [MoA]", "Protein Synthesis Inhibitors [MoA]"], "product_ndc": "55150-928", "generic_name": "DACTINOMYCIN", "labeler_name": "Eugia US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DACTINOMYCIN", "active_ingredients": [{"name": "DACTINOMYCIN", "strength": ".5 mg/mL"}], "application_number": "ANDA203385", "marketing_category": "ANDA", "marketing_start_date": "20210315", "listing_expiration_date": "20261231"}